These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32577665)

  • 1. Broad and strong memory CD4
    Peng Y; Mentzer AJ; Liu G; Yao X; Yin Z; Dong D; Dejnirattisai W; Rostron T; Supasa P; Liu C; Lopez-Camacho C; Slon-Campos J; Zhao Y; Stuart D; Paeson G; Grimes J; Antson F; Bayfield OW; Hawkins DE; Ker DS; Turtle L; Subramaniam K; Thomson P; Zhang P; Dold C; Ratcliff J; Simmonds P; de Silva T; Sopp P; Wellington D; Rajapaksa U; Chen YL; Salio M; Napolitani G; Paes W; Borrow P; Kessler B; Fry JW; Schwabe NF; Semple MG; Baillie KJ; Moore S; Openshaw PJ; Ansari A; Dunachie S; Barnes E; Frater J; Kerr G; Goulder P; Lockett T; Levin R; Cornall RJ; Conlon C; Klenerman P; McMichael A; Screaton G; Mongkolsapaya J; Knight JC; Ogg G; Dong T
    bioRxiv; 2020 Jun; ():. PubMed ID: 32577665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad and strong memory CD4
    Peng Y; Mentzer AJ; Liu G; Yao X; Yin Z; Dong D; Dejnirattisai W; Rostron T; Supasa P; Liu C; López-Camacho C; Slon-Campos J; Zhao Y; Stuart DI; Paesen GC; Grimes JM; Antson AA; Bayfield OW; Hawkins DEDP; Ker DS; Wang B; Turtle L; Subramaniam K; Thomson P; Zhang P; Dold C; Ratcliff J; Simmonds P; de Silva T; Sopp P; Wellington D; Rajapaksa U; Chen YL; Salio M; Napolitani G; Paes W; Borrow P; Kessler BM; Fry JW; Schwabe NF; Semple MG; Baillie JK; Moore SC; Openshaw PJM; Ansari MA; Dunachie S; Barnes E; Frater J; Kerr G; Goulder P; Lockett T; Levin R; Zhang Y; Jing R; Ho LP; ; ; Cornall RJ; Conlon CP; Klenerman P; Screaton GR; Mongkolsapaya J; McMichael A; Knight JC; Ogg G; Dong T
    Nat Immunol; 2020 Nov; 21(11):1336-1345. PubMed ID: 32887977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breadth and Durability of SARS-CoV-2-Specific T Cell Responses following Long-Term Recovery from COVID-19.
    Dang TTT; Anzurez A; Nakayama-Hosoya K; Miki S; Yamashita K; de Souza M; Matano T; Kawana-Tachikawa A
    Microbiol Spectr; 2023 Aug; 11(4):e0214323. PubMed ID: 37428088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel detection of SARS-CoV-2 epitopes reveals dynamic immunodominance profiles of CD8
    van den Dijssel J; Hagen RR; de Jongh R; Steenhuis M; Rispens T; Geerdes DM; Mok JY; Kragten AH; Duurland MC; Verstegen NJ; van Ham SM; van Esch WJ; van Gisbergen KP; Hombrink P; Ten Brinke A; van de Sandt CE
    Clin Transl Immunology; 2022; 11(10):e1423. PubMed ID: 36254196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunodominant SARS-CoV-2-specific CD4
    Ning J; Wang Q; Chen Y; He T; Zhang F; Chen X; Shi L; Zhai A; Li B; Wu C
    J Med Virol; 2023 Apr; 95(4):e28743. PubMed ID: 37185843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine.
    Chen Y; Yin S; Tong X; Tao Y; Ni J; Pan J; Li M; Wan Y; Mao M; Xiong Y; Yan X; Yang Y; Huang R; Wu C; Shen H
    Clin Microbiol Infect; 2022 Mar; 28(3):410-418. PubMed ID: 34715346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells.
    Phetsouphanh C; Khoo WH; Jackson K; Klemm V; Howe A; Aggarwal A; Akerman A; Milogiannakis V; Stella AO; Rouet R; Schofield P; Faulks ML; Law H; Danwilai T; Starr M; Munier CML; Christ D; Singh M; Croucher PI; Brilot-Turville F; Turville S; Phan TG; Dore GJ; Darley D; Cunningham P; Matthews GV; Kelleher AD; Zaunders JJ
    Front Immunol; 2022; 13():1032911. PubMed ID: 36544780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T Cell Immunity Evaluation and Immunodominant Epitope T Cell Receptor Identification of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Glycoprotein in COVID-19 Convalescent Patients.
    Li L; Chen Q; Han X; Shen M; Hu C; Chen S; Zhang J; Wang Y; Li T; Huang J; Li S; Hao Y; Jin A
    Front Cell Dev Biol; 2021; 9():696662. PubMed ID: 34805136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of multi-epitope peptide-based vaccines against SARS-CoV-2.
    Lim HX; Lim J; Jazayeri SD; Poppema S; Poh CL
    Biomed J; 2021 Mar; 44(1):18-30. PubMed ID: 33727051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV-2?
    Hellerstein M
    Vaccine X; 2020 Dec; 6():100076. PubMed ID: 32875286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients.
    Maghsood F; Shokri MR; Jeddi-Tehrani M; Torabi Rahvar M; Ghaderi A; Salimi V; Kardar GA; Zarnani AH; Amiri MM; Shokri F
    Pathog Dis; 2022 Feb; 80(1):. PubMed ID: 34994386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of SARS-CoV-2 public CD4+ αβ T cell clonotypes through reverse epitope discovery.
    Rosati E; Pogorelyy MV; Minervina AA; Scheffold A; Franke A; Bacher P; Thomas PG
    bioRxiv; 2021 Nov; ():. PubMed ID: 34845450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.